All Stories

  1. Serial measurement of type-specific human papillomavirus load enables classification of cervical intraepithelial neoplasia lesions according to occurring human papillomavirus-induced pathway
  2. Linear viral load increase of a single HPV-type in women with multiple HPV infections predicts progression to cervical cancer
  3. GTL001, A Therapeutic Vaccine for Women Infected with Human Papillomavirus 16 or 18 and Normal Cervical Cytology: Results of a Phase I Clinical Trial
  4. Surveillance of effects of HPV vaccination in Belgium
  5. VALGENT: A protocol for clinical validation of human papillomavirus assays
  6. Screening for abnormal vaginal microflora by self-assessed vaginal pH does not enable detection of sexually transmitted infections in Ugandan women
  7. Human Papillomavirus Positivity in Women Undergoing Intrauterine Insemination Has a Negative Effect on Pregnancy Rates
  8. Early effects of human papillomavirus vaccination in Belgium
  9. individual tissue section with viral load to identify HPV types in lesions that cause the disease
  10. multiple HPV infection in south African women with cervical cancer
  11. Serial type-specific human papillomavirus (HPV) load measurement allows differentiation between regressing cervical lesions and serial virion productive transient infections
  12. Are 20 human papillomavirus types causing cervical cancer?
  13. Identification of Protein Biomarkers for Cervical Cancer Using Human Cervicovaginal Fluid
  14. Bead-based multiplex sexually transmitted infection profiling
  15. High frequency of genital human papillomavirus infections and related cervical dysplasia in adolescent girls in Belgium
  16. Association of Trichomonas vaginalis and Cytological Abnormalities of the Cervix in Low Risk Women
  17. Screening for Cervical Cancer Precursors With p16/Ki-67 Dual-Stained Cytology: Results of the PALMS Study
  18. Increased Prevalence of Trichomonas vaginalis in Mid-Aged Women Is Linked to Sexual Activity and Not to Hormonal Changes
  19. Cervical cancer screening: which HPV test should be used—L1 or E6/E7?
  20. Human papillomavirus predicts the outcome following concomitant chemoradiotherapy in patients with head and neck squamous cell carcinomas
  21. Multiple Human Papillomavirus Infections with High Viral Loads Are Associated with Cervical Lesions but Do Not Differentiate Grades of Cervical Abnormalities
  22. Viral Load of High-Risk Human Papillomaviruses as Reliable Clinical Predictor for the Presence of Cervical Lesions
  23. Changes in type-specific human papillomavirus load predict progression to cervical cancer
  24. Prevalence and viral load of 51 genital human papillomavirus types and three subtypes
  25. Clinical Validation of a Type-Specific Real-Time Quantitative Human Papillomavirus PCR against the Performance of Hybrid Capture 2 for the Purpose of Cervical Cancer Screening
  26. Human papillomavirus, lichen sclerosus and penile cancer: A study in Belgium
  27. Anal human papillomavirus DNA in women at a colposcopy clinic
  28. Human papillomavirus DNA strongly correlates with a poorer prognosis in oral cavity carcinoma
  29. High-throughput detection, genotyping and quantification of the human papillomavirus using real-time PCR
  30. Don’t Forget HPV-45 in Cervical Cancer ScreeningThe Authors’ Reply
  31. Role of Protein Biomarkers in the Detection of High-Grade Disease in Cervical Cancer Screening Programs
  32. Prior knowledge of HPV status improves detection of CIN2+ by cytology screening
  33. High incidence of high-risk HPV in benign and malignant lesions of the larynx
  34. High Prevalence of High-Risk Human Papillomavirus in Palatine Tonsils from Healthy Children and Adults
  35. Type-specific HPV geno-typing improves detection of recurrent high-grade cervical neoplasia after conisation
  36. BD-ProExC as Adjunct Molecular Marker for Improved Detection of CIN2+ after HPV Primary Screening
  37. Serum Epstein–Barr virus (EBV) viral load can be a complementary sensitive test in primary Epstein–Barr virus infection
  38. Myopathy with hexagonally cross-linked crystalloid inclusions: Delineation of a clinico-pathological entity
  39. Nucleic Acid Sequence-Based Amplification Assay for Human Papillomavirus mRNA Detection and Typing: Evidence for DNA Amplification
  40. Combined analysis of HPV DNA, p16, p21 and p53 to predict prognosis in patients with stage IV hypopharyngeal carcinoma
  41. Association of HIV infection with distribution and viral load of HPV types in Kenya: a survey with 820 female sex workers
  42. Biomarkers in cervical screening: quantitative reverse transcriptase PCR analysis of P16INK4a expression
  43. Epidemiology of Trichomonas vaginalis and Human Papillomavirus Infection Detected by Real-Time PCR in Flanders
  44. Human Papillomavirus 16 Load and E2/E6 Ratio in HPV16-Positive Women: Biomarkers for Cervical Intraepithelial Neoplasia >=2 in a Liquid-Based Cytology Setting?
  45. Prevaccination Distribution of Human Papillomavirus Types in Women Attending at Cervical Cancer Screening in Belgium
  46. Quality control for normal liquid-based cytology: Rescreening, high-risk HPV targeted reviewing and/or high-risk HPV detection?
  47. Cervical cytology biobanking: quality of DNA from archival cervical Pap-stained smears
  48. Effects of fixation on RNA integrity in a liquid-based cervical cytology setting
  49. Urine versus brushed samples in human papillomavirus screening: study in both genders
  50. Comparison of MY09/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV types
  51. Improved endocervical sampling and HPV viral load detection by Cervex-Brush�Combi
  52. Correlation between laminin-5 immunohistochemistry and human papillomavirus status in squamous cervical carcinoma
  53. Immunocytochemistry in liquid-based cervical cytology: Analysis of clinical use following a cross-sectional study
  54. P16INK4a as an adjunct marker in liquid-based cervical cytology
  55. Ki-67 immunocytochemistry in liquid based cervical cytology: useful as an adjunctive tool?
  56. Age-restricted cervical screening
  57. Relationship between seminal plasma–soluble transferrin receptor and spermatogenesis in azoospermic patients
  58. Thin-layer liquid-based cervical cytology and PCR for detecting and typing human papillomavirus DNA in Flemish women
  59. The effects of combined conventional treatment, oral antioxidants and essential fatty acids on sperm biology in subfertile men
  60. Which efforts towards conservative treatment of male infertility will be successful? Reactive oxygen species, antioxidants, and sperm phospholipids
  61. Mechanisms and effects of male genital tract infection on sperm quality and fertilizing potential: the andrologist's viewpoint
  62. The clinical and biologic significance of serum inhibins in subfertile men
  63. Pathophysiological effect of varicocele treatment
  64. Seminal plasma alpha-glucosidase activity and male infertility
  65. The fatty acid composition of phospholipids of spermatozoa from infertile patients
  66. Purification and characterization of hepatocyte growth factor (HGF) from human seminal plasma
  67. Genetic regulation of gametogensis
  68. MedCalc: a new computer program for medical statistics